Company intelligence / Profile preview
Rxilient Health
Singapore, Singaporerxilient.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Rxilient Health focuses on developing, registering, supplying, and commercializing pharmaceutical products for emerging markets, particularly in Southeast Asia. It has a portfolio of over ten differentiated products and is working on registering innovative pipeline products.
- Therapeutic areas
- OncologyImmunologyDermatologyOphthalmologyNeurology
- Modalities
- Small moleculesmonoclonal antibodies (e.g., toripalimab)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Junshi Biosciences for toripalimab
Beyond the preview
Go deeper on Rxilient Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rxilient Health.